What is Agilent Technologies's market cap?

Agilent Technologies (A) has a market capitalization of $37.7B and trades on NYSE.

What is Agilent Technologies's revenue and profitability?

Agilent Technologies generated $7.2B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 19.6%. Gross margin stands at 52.7%, with free cash flow of $1.1B. These figures are based on the Q2 2026 filing.

Who are Agilent Technologies's competitors?

Agilent Technologies's key competitors include Thermo Fisher Scientific, PerkinElmer, Danaher Corporation, and others. These companies compete in similar markets and product categories.

What subsidiaries does Agilent Technologies have?

Agilent Technologies's subsidiaries include BIOVECTRA.

Where is Agilent Technologies headquartered?

Agilent Technologies is headquartered in United States of America and employs approximately 17,600 people. It has been publicly traded since 1999.

Agilent Technologies

Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing comprehensive laboratory workflow solutions.

Market cap

$37.73B+7.0%

Revenue$7.2B+9.1%

Net income$1.4B+21.3%

Free cash flow$1.1B-8.6%

EPS (diluted)$4.97+22.4%

Trailing twelve months · change vs. prior year

Table of contents

Earnings

Q2 2026 report

May 27, 2026

Revenue$1.8BBeat by $36.5M EPS$1.49Beat by $0.08

Read the full report

Next report

Aug 26, 2026 (in a month)

Revenue estimate$1.8B

EPS estimate$1.47

Financials

Q2 2026

Income statement

See full

Revenue$1.8B+10.0%

Gross profit$990.0M+14.3%

Operating income$399.0M+33.0%

Net income$339.0M+57.7%

EPS (diluted)$1.20+60.0%

Balance sheet

See full

Cash & equivalents$1.8B+21.5%

Total debt$3.5B-3.9%

Total equity$7.1B+16.1%

Total assets$13.1B+7.5%

Cash flow

See full

Operating cash flow$277.0M+25.3%

CapEx$76.0M-33.3%

Free cash flow$201.0M+87.9%

Valuation & ratios

Valuation

See full

Market cap$37.73B+7.0%

Enterprise value$39.46B+9.4%

P/E26.7×-2.4×

P/S5.2×+0.1×

Profitability

See full

Gross margin52.7%-0.6pp

Operating margin21.5%+0.1pp

Net margin19.6%+2.0pp

FCF margin15%-2.9pp

Returns & leverage

See full

Return on equity21.3%+2.4pp

Debt / equity0.5×-0.1×

Current ratio2.1×0.0×

Segments

By segment

See full

Agilent CrossLab$759.0M+6.5%

Life Sciences and Diagnostics Markets$732.0M+11.9%

Applied Markets$344.0M+14.3%

By geography

See full

Americas$764.0M+12.7%

Asia Pacific$553.0M+0.9%

Europe$518.0M+17.2%

Competitors

By market cap

Thermo Fisher Scientific$194.99B+23.4%

Abbott$164.43B-29.3%

Danaher$138.71B-2.9%

Agilent Technologies$37.7B+11.4%

WAT

Waters Corporation$37.0B+79.5%

Revvity$12.6B+8.3%

Bio-Rad Laboratories$8.0B+18.3%

Fulgent Genetics, Inc.$593.0M+1.0%

By revenue growth

WAT

Waters Corporation+26.4%

Fulgent Genetics, Inc.+9.5%

Agilent Technologies+9.1%

Abbott+6.6%

Revvity+4.8%

Danaher+4.0%

Thermo Fisher Scientific+2.4%

Bio-Rad Laboratories+1.9%

By net margin

Agilent Technologies19.55%+2.0pp

Thermo Fisher Scientific15.19%+0.4pp

Danaher14.89%-0.9pp

Abbott13.91%-18.0pp

WAT

Waters Corporation11.91%-10.1pp

Revvity8.26%-2.1pp

Bio-Rad Laboratories6.52%+91.7pp

Fulgent Genetics, Inc.-23.04%-9.1pp

Profile

Agilent Technologies is a global leader in life sciences, diagnostics, and applied markets, providing comprehensive laboratory workflow solutions. The company delivers a specialized portfolio of instruments, software, consumables, and services designed to help scientists and clinicians identify, quantify, and analyze biological and chemical properties. Their value proposition centers on application-focused solutions that span from basic research to clinical diagnostics and pharmaceutical manufacturing.

Competitive position

A leading global provider of laboratory workflow solutions with a dominant presence in chromatography and mass spectrometry.

GeographiesUnited States, China, Europe, Asia Pacific

Customer segmentsHealthcare Providers, Pharmaceutical & Biotech, Industrial & Applied Markets, Academic & Government

Business modelManufacturing, Contract Development and Manufacturing (CDMO), Professional Services, Consumables and Recurring Revenue

SuppliersElectronic component suppliers, Raw chemical and reagent providers, Specialized metal and glass manufacturers, Software developers

CustomersHospitals and Diagnostic Centers, Pharmaceutical R&D departments, Quality control laboratories, Environmental monitoring agencies

CountryUnited States of America

Listed1999

Employees17.6K

CEOPadraig McDonnell

SectorHealthcare

IndustryMedical - Diagnostics & Research

Websiteagilent.com

FilingsSEC EDGAR

Ask your AI about Agilent Technologies.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Agilent Technologies's market cap?: Agilent Technologies (A) has a market capitalization of $37.7B and trades on NYSE.
What is Agilent Technologies's revenue and profitability?: Agilent Technologies generated $7.2B in trailing twelve-month revenue with net income of $1.4B, representing a net margin of 19.6%. Gross margin stands at 52.7%, with free cash flow of $1.1B. These figures are based on the Q2 2026 filing.
Who are Agilent Technologies's competitors?: Agilent Technologies's key competitors include Thermo Fisher Scientific, PerkinElmer, Danaher Corporation, and others. These companies compete in similar markets and product categories.
What subsidiaries does Agilent Technologies have?: Agilent Technologies's subsidiaries include BIOVECTRA.
Where is Agilent Technologies headquartered?: Agilent Technologies is headquartered in United States of America and employs approximately 17,600 people. It has been publicly traded since 1999.